FemmeHealth Ventures Alliance

FemmeHealth Ventures Alliance

Share this post

FemmeHealth Ventures Alliance
FemmeHealth Ventures Alliance
The $672M Power Play: How Cosette’s Acquisition of Mayne Pharma Signals a New Era in Women’s Health Investing

The $672M Power Play: How Cosette’s Acquisition of Mayne Pharma Signals a New Era in Women’s Health Investing

Women’s health is evolving and no longer a "niche play". Here’s what this multi-million dollar deal reveals about the future of M&A, private capital, and high-growth opportunities in the space.

Maryann's avatar
Maryann
Feb 23, 2025
∙ Paid
21

Share this post

FemmeHealth Ventures Alliance
FemmeHealth Ventures Alliance
The $672M Power Play: How Cosette’s Acquisition of Mayne Pharma Signals a New Era in Women’s Health Investing
5
9
Share

Welcome to the latest issue of the Femmehealth Ventures Publication—your trusted source for insightful analysis of femtech innovations through an investor's lens, helping you identify the latest opportunities in women's health technology.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Maryann
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share